MedTrace Logo

Mortality and Cardiovascular Diseases in Adult-onset Type 1 Diabetes

NCT06563401 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 900000

Last updated 2025-04-03

No results posted yet for this study

Summary

Scarce evidence is available for prognosis in adult-onset type 1 diabetes (T1D). The aim of this study is to investigate the risk of all-cause mortality, cause-specific mortality, and incident CVD in adult-onset T1D, as compared to type 2 diabetes with comparable age at diagnosis and population controls. We will explore potential modifiable factors including lifestyle and clinical characteristics that contribute to T1D prognosis. In addition, we will estimate the life expectancy associated with different age at T1D diagnosis as compared to population controls. This study will be based on people with diabetes recorded in Swedish National Diabetes Registers, with linkages to other nationwide registers to retrieve data on lifestyle factors, biomarkers, treatment and outcome information.

Conditions

Interventions

OTHER

prognosis of adult-onset t1d

We are comparing mortality and vascular outcomes in adult-onset T1D to T2D and diabetes-free people

Sponsors & Collaborators

Principal Investigators

  • Sofia Carlsson, phd · sofia carlsson, senior lecturer, Karolinska Institutet

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2025-05-31
Completion
2025-07-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06563401 on ClinicalTrials.gov